Introduction
Calamus is an aromatic marsh plant (Acorus calamus). For centuries, people have used its rhizome as a bitter. Today, experts view the plant much more critically due to its potential toxicity.
This text discusses its origin, uses, and risks. An important point to note upfront: There is a lack of clinical data regarding its use in “treating” serious illnesses; and there are toxicological warnings regarding constituents such as β-asarone.
What calamus is and how it came to Europe
The part of the plant used is the rhizome. It grows primarily in riparian zones; the plant produces sword-shaped leaves, and the flower spike appears inconspicuously greenish.
Regarding its “discovery” in the context of medical history: According to WALA, calamus was already valued in India around 3,000 years ago and mentioned in the Yajur Veda. In Central Europe, calamus did not become widespread until much later. WALA cites its introduction around 1560 as the catalyst. According to this account, the physician and botanist Pietro Andrea Matthioli brought the plant back after a trip to Constantinople.
In Europe, the plant was primarily regarded as an aromatic-bitter remedy for stomach ailments. However, historical sources also cited it for many other purposes (e.g., against “consumption”). This is worth noting.
Active Ingredients and Effects on the Body
Pharmacologically relevant is primarily a mixture of essential oil, bitter compounds, and tannins. WALA describes root extracts as supportive for stomach, intestinal, and gallbladder complaints. They are also said to stimulate digestion. This primarily refers to functional complaints without an organic cause.
The catch: The composition varies greatly depending on variety and origin. Scientific reviews describe different phenotypes: The Indian, tetraploid variety usually contains a high amount of β-asarone. North American diploid plants, on the other hand, are considered β-asarone-free. European plants fall somewhere in between.
β-asarone, in particular, is the compound at the center of the safety debate. The European Medicines Agency (EMA) classifies α- and β-asarone as genotoxic and hepatocarcinogenic in rodent models and recommends reducing the concentration of these compounds in herbal medicines as much as possible; diploid varieties should be preferred.
Calamus: Forms of Administration and Dosage in Practice
Traditionally, people use the rhizome as tea, tincture, or powder. In Germany, there are ready-made teas made from dried calamus root; an example is provided by the dosage instructions for a pharmacy product: brew about 1 teaspoon (approx. 1.5 g) per cup, up to two cups spread throughout the day.
Some guides recommend taking it before meals to use the bitter taste as a “starting signal” for digestion. At the same time, such sources also emphasize that many species contain β-asarone and therefore caution is necessary.
Importantly: Reliable clinical studies on dosage are largely lacking. Drugs.com puts it bluntly: Due to toxicity concerns and a lack of clinical data, calamus cannot be recommended for any purpose; in the U.S., its use and addition to food are prohibited.
If anything, toxicological assessments tend to argue against high doses and long-term use. The EMA sets a provisional limit of around 115 µg of β-asarone per day for herbal medicines. This corresponds to about 2 µg per kilogram of body weight daily. This value is considered only a temporary solution.
One point that is often overlooked: Some products refer to tea or aqueous extracts, whereas the essential rhizome oil is a highly concentrated mixture. Safety data for this oil suggest a more cautious approach: A modern in vitro safety assessment classified the rhizome oil as a Category 2 skin irritant. It was also considered highly sensitizing (GHS Category 1B). β-Asaron was a major component in this.
In practical terms, this means: If you use a preparation at all, then only for a short time and at a low dose—and not as a self-experiment with oil or highly concentrated extracts. This caution is also in line with EMA recommendations to minimize asaron content and to preferentially use asaron-poor (diploid) varieties.
What calamus was traditionally used for—and what is considered “treatable”
Here, a clear distinction between tradition and evidence is warranted. What has been relatively consistently handed down: Calamus was used internally primarily for loss of appetite, bloating, a “sensitive stomach,” and functional digestive complaints. WALA describes exactly this scenario and even explicitly mentions complaints “without organic disease” as a context for a course of tea.
Added to this are historical or ethnomedical uses that often appear in modern reviews (e.g., for coughs, fever, or as a remedy for nervous conditions). Such lists tend to show how widely a plant was used culturally, not that it reliably cures diseases.
What does the research say? In vitro and animal data describe anti-inflammatory, antimicrobial, or neuroactive effects for extracts and individual compounds (α-/β-asarone), among others; Drugs.com, for example, cites studies regarding epilepsy, diabetes, or Alzheimer’s—but emphasizes at the same time that clinical trials are lacking.
Conclusion: There is no solid clinical evidence for serious illnesses. A healing claim is therefore not justified. At best, symptomatic relief for mild, functional gastrointestinal complaints is realistic—and even then, safety and the risk-benefit ratio are paramount.
Risks, Side Effects, and Who Should Avoid It
Safety is the most important consideration. In the U.S., foods containing added calamus, calamus oil, or extract are considered “adulterated” based on a 1968 FDA regulation (21 CFR 189.110).
The EU prohibits the intentional addition of beta-asarone to foods. For naturally occurring levels, it sets maximum limits (e.g., 1.0 mg/kg in alcoholic beverages).
The EU Scientific Committee (SCF) also reached a firm conclusion in its risk assessment: Due to in vitro genotoxicity, no safe threshold can be assumed; therefore, a “safe” exposure limit could not be established. Consequently, limits on exposure and usage levels are advisable.
Possible side effects primarily affect the gastrointestinal tract and the nervous system. Drugs.com reports, among other things, case reports of nausea, prolonged vomiting, and tachycardia; there is also data on tumor development following long-term administration in animal studies.
Who should be particularly cautious or avoid it?
- Pregnancy/Breastfeeding: Avoid, among other reasons due to documented adverse effects and genotoxic activity.
- Infants/Toddlers: A clinical case series describes deaths in newborns following complications associated with ‘vasambu’ (A. calamus). This is a clear warning sign.
- People taking multiple medications: Interactions are not “well documented,” but there is evidence of possible effects via CYP enzymes as well as potential interactions with, for example, calcium channel blockers or antiepileptics (animal data).
What happens if you take too much calamus?
- Acute: Nausea, vomiting, circulatory reactions; cases of poisoning also showed a rapid heart rate and severe symptoms.
- Long-term/high doses: The main problem is not “greater efficacy,” but a potential cancer risk associated with products containing asaron—at least plausible based on animal data and genotoxicological evidence.
Complementary plants and better alternatives
If your goal is to stimulate digestion through bitterness, there are traditionally well-established combinations that are used more frequently in Europe than pure calamus self-medication. One example is a herbal bitter made from several bitter herbs such as wormwood, angelica, bitter orange, and spices—where calamus appears as one ingredient among many.
In the context of anthroposophy: WALA uses calamus in combination with gentian, ginger, pepper, and wormwood in a bitter elixir or stomach tonic to stimulate peptic digestive activity (loss of appetite, bloating, nausea).
In food products, calamus is primarily of historical relevance today: calamus oil was and is primarily discussed in relation to bitter spirits and flavored beverages; at the same time, regulations limit the content of problematic ingredients.
Sources & Studies
https://ec.europa.eu/food/fs/sc/scf/out111_en.pdf
https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-189/subpart-C/section-189.110
https://www.walaarzneimittel.de/heilpflanzenlexikon-a-z/kalmus
https://www.drugs.com/npp/calamus.html
https://www.mdpi.com/2305-6304/13/12/1006
https://www.sciencedirect.com/science/article/abs/pii/S0367326X10002893
https://www.sciencedirect.com/science/article/pii/S0944711317300533
Published on: 31. March 2026
Related posts
Ayurveda, Herbal healing, Supplementation, Traditional Chinese Medicine
Herbal healing, Naturopathy, Traditional Chinese Medicine


